

Axcella Information
Contact top employees from
Axcella
Summary
Axcella is a public company that has been in the industry for 15 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by William Hinshaw. Its headquarters is located at Cambridge, Massachusetts, USA. The number of employees ranges from 25 to 100. The Axcella annual revenue is estimated at < 1M. Total funding of the company - $158.2M. To connect with Axcella employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
SIC Code
2836
DMA Code
Greater Boston
Founded
2010
Operating Status
Independent Company
Contact Axcella
Organization Website
Social Links
Contact Email
info@axcellahealth.com
Phone Number
857-320-2200, 617-441-6243
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2018 | Privately Held | 1 - 25 | 6M | $109.5M | |
2007 | Public Company | 25 - 100 | 15M | $210.9M | |
2010 | Public Company | 250 - 500 | 1.1B | $843M | |
1998 | Privately Held | 250 - 500 | 300M | $125M | |
2011 | Privately Held | 25 - 100 | 2.9M | $40M | |
1987 | Public Company | 500 - 1.0K | 928.5M | $2.3B | |
2001 | Public Company | 25 - 100 | 14M | $379.4M | |
2008 | Privately Held | 250 - 500 | 40.9M | $923.3M | |
2005 | Public Company | 25 - 100 | 25.2M | $76M | |
2013 | Privately Held | 250 - 500 | 93.5M | $377.8M | |
2009 | Privately Held | 1 - 25 | 16.7M | $10.1M | |
2014 | Public Company | 100 - 250 | 132.2M | $267.1M | |
2007 | Privately Held | 25 - 100 | 7.9M | $138.6M | |
2009 | Privately Held | 25 - 100 | 5.6M | $197.7M | |
2000 | Privately Held | 500 - 1.0K | 21.4M | $1.5B | |
2009 | Public Company | 1.0K - 5.0K | 45M | $634.9M | |
2015 | Public Company | 25 - 100 | 1.5M | $211.5M | |
2010 | Privately Held | 25 - 100 | 8M | $308.6M | |
1993 | Public Company | 1.0K - 5.0K | 50.2M | $526.4M | |
2009 | Privately Held | 25 - 100 | 12M | $68.7M | |
2010 | Public Company | 1.0K - 5.0K | 7B | $3.6B | |
2010 | Public Company | 100 - 250 | 30M | $267.9M | |
2003 | - | 1 - 25 | 4.6M | $32.2M | |
1999 | Public Company | 50K - 100K | 29.5B | $0 | |
1848 | Public Company | 50K - 100K | 55.5B | $0 | |
1981 | Public Company | 100 - 250 | 135.1M | $0 | |
2012 | - | - | $- | ||
2015 | - | 100-200 | - | $- | |
1896 | - | 10000+ | - | $- | |
2008 | - | 1000-5000 | - | $- | |
2008 | - | 10-50 | - | $- | |
1995 | - | 200-500 | - | $- | |
2007 | - | 200-500 | - | $- | |
2002 | - | 1000-5000 | - | $- | |
2014 | - | 100-200 | - | $- | |
2004 | - | 500-1000 | - | $- | |
- | - | 10-50 | - | $- | |
- | - | 500-1000 | - | $- | |
- | - | 1-10 | - | $- | |
- | - | 1-10 | - | $- |
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at Axcella shows a diverse range of experience levels:
2% for 1–2 years8% for 3–4 years20% for 5–7 years49% for 8–10 years22% have over 11 years of service at AxcellaContact top employees from
Axcella
Murat Cokol
Director of Computational Biology
William Hinshaw
President and CEO
Karim Azer
VP, Head of Platform & Discovery
Erica Player
Executive Assistant
Majed Fawaz
Senior Director Analytical & Formulation Development
Gianluca De Rienzo
Senior Scientist
Marie Washburn
VP, Finance & Corporate Controller
Timothy Campbell
Director of FP&A
Philip Lao
Vice President – Business Development & Licensing
Cerasela Albei
Senior Medical Director
Marilyn Montero
Executive Assistant
Ian Parsons
Director of Analytical Development
David Isaac
Technical Lead Manager
Jeya Kannan
Intern
Saleem Saleem
Sales And Marketing Specialist
Ralph Yamamoto
Senior Director of Analytical Science and Technology
Similar Companies
FAQ
Axcella operates in the Biotechnology industries. More details can be found on the official website: axcellatx.com.
The headquarters of Axcella are located in Cambridge, United States.
The current CEO of Axcella is William Hinshaw
You can contact Axcella by phone at 857-320-2200, 617-441-6243.
Axcella currently employs 100-200 people.
Axcella's revenue is approximately < 1M.
Well-known competitors of Axcella include Aro Biotherapeutics, Regulus Therapeutics, Sage Therapeutics and InterMune.